<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Voyager Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Voyager Therapeutics, Inc.

    Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $360,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Andre Turenne
    • FOUNDED
      2013
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Therapix Biosciences Ltd.

    Therapix Biosciences Ltd.

    Therapix Biosciences Ltd. (NASDAQ: TRPX) is a specialty clinical-stage pharmaceuti...

    Therapix Biosciences Ltd. (NASDAQ: TRPX) is a s...

    Filing Type:    PU

    Predictive Oncology Inc.

    Predictive Oncology is a clinical and translational data pipeline and AI-driven pl...

    Predictive Oncology is a clinical and translati...

    Filing Type:    PU
    Vascular Biogenics Ltd.

    Vascular Biogenics Ltd.

    VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biopharm...

    VBL Therapeutics is a publicly traded (NASDAQ: ...

    Filing Type:    PU
    Nature's Sunshine Products, Inc.

    Nature's Sunshine Products, Inc.

    Nature’s Sunshine Products (NASDAQ:NATR), a leading natural health and wellness ...

    Nature’s Sunshine Products (NASDAQ:NATR), a l...

    Filing Type:    PU
    Seattle Genetics, Inc.

    Seattle Genetics, Inc.

    Founded 20 years ago, Seattle Genetics was built on a foundation of scientific inn...

    Founded 20 years ago, Seattle Genetics was buil...

    Filing Type:    PU
    Eyenovia, Inc.

    Eyenovia, Inc.

    Eyenovia is a late-stage ophthalmic biopharmaceutical company developing breakthro...

    Eyenovia is a late-stage ophthalmic biopharmace...

    Filing Type:    PU
    Axsome Therapeutics, Inc.

    Axsome Therapeutics, Inc.

    Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing...

    Axsome Therapeutics, Inc. is a clinical-stage b...

    Filing Type:    PU
    Supernus Pharmaceuticals, Inc.

    Supernus Pharmaceuticals, Inc.

    Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing a...

    Supernus Pharmaceuticals, Inc. is a pharmaceuti...

    Filing Type:    PU
    VistaGen Therapeutics, Inc.

    VistaGen Therapeutics, Inc.

    VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company...

    VistaGen Therapeutics (NASDAQ: VTGN) is a clini...

    Filing Type:    PU
    Tocagen Inc.

    Tocagen Inc.

    Tocagen is a clinical-stage, cancer-selective gene therapy company developing firs...

    Tocagen is a clinical-stage, cancer-selective g...

    Filing Type:    PU
    Genprex, Inc.

    Genprex, Inc.

    Genprex Inc is a U.S.-based clinical-stage gene therapy company. It is engaged in ...

    Genprex Inc is a U.S.-based clinical-stage gene...

    Filing Type:    PU
    Fortress Biotech, Inc.

    Fortress Biotech, Inc.

    Fortress Biotech ("Fortress" or "the Company") is an innovative biopharmaceutical ...

    Fortress Biotech ("Fortress" or "the Company") ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.